Moritz Fürstenau, MD

Articles by Moritz Fürstenau, MD

GAIA/CLL13 Trial Follow-Up Compares Venetoclax Combinations in CLL

Melissa BadamoChronic Lymphocytic Leukemia | July 18, 2024

Venetoclax plus obinutuzumab was associated with longer PFS compared with chemoimmunotherapy.